Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02c5a6e163326367b73153104e81fb92 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate |
2020-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a60a8a84e0a84fd2f77d5292a78c44a6 |
publicationDate |
2021-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2021042166-A1 |
titleOfInvention |
Methods for confirming detection and evaluating the progression of a prostate cancer and related therapies |
abstract |
The present invention relates to methods for detecting prostate cancer, methods for reliable prostate cancer grading, methods for determining the progression of prostate cancer, methods for defining advanced prostate cancer, and methods for treating prostate cancer patients based on the detection of biomarkers. In particular, the present disclosure is based on the determination that a combination of three specific endosomal biomarkers can be used to detect prostate cancer and/or determine the degree of progression of such cancer in a subject. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022253604-A1 |
priorityDate |
2019-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |